WASHINGTON — Senators grilled FDA Commissioner Robert Califf Wednesday on everything from the agency’s stance on a Texas court’s attempt to ban the abortion pill mifepristone to the uptick in clinical trial holds for cell and gene therapies.
Califf has been making the rounds on Capitol Hill to discuss President Biden’s budget request for the Food and Drug Administration, and the appearances give lawmakers a chance to buttonhole him on budget items as well as politically explosive issues that have nothing to do with the funding request.
Cell and gene therapies: Sen. Susan Collins (R-Maine) said the FDA is putting holds on clinical trials of promising therapies without explanation.
About the Author Reprints
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.